Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-01-07

Clinical Trial Update: Efficacy and Safety of Liuwei Dihuang Pill Versus Placebo in Presbycusis With Shen (Kidney)-Yin Deficiency [Phase 2]

View source ↗

Summary

Phase 2 study comparing Liuwei Dihuang Pill to placebo to evaluate efficacy and safety in presbycusis with Kidney-Yin deficiency. The trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Liuwei Dihuang Pill

Snippet

Sponsor: Shanghai Jiao Tong University School of Medicine | Conditions: Presbycusis, Age-related Hearing Loss | Phase 2 | Status: COMPLETED